Inhibition of LSD1, either through RNA interference or with an allosteric LSD1 inhibitor (SP2509), has been shown to reactivate TP53 tumor suppressor pathways and reduce NEPC tumor growth.83 This evidence concerns the gene TP53 and neoplasm.